On-line Enduring Material Teaches on Adrenal Nodules

OSUWexnerbloglogo2014 On-line Enduring Material Teaches on Adrenal Nodules. Pheochromocytomas are fairly rare with about 1,000 cases in the U.S. every year but overall, adrenal tumors are common, and you can find one in about every 20 patients who undergo abdominal CT scans. Most of these adrenal tumors are benign and require no treatment but knowing which ones are consequential and which ones are inconsequential can be a challenge. On this CME webcast, to show you how to manage the incidentally identified adrenal tumor is surgical oncologist and Assistant Professor of Surgery at the Ohio State University, we have Dr. Drew Shirley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the imaging characteristics used to determine treatment strategies for adrenal nodules; and USE biochemical tests to aid in the diagnosis of functional adrenal nodules.

You’ll also learn about the following:

  • Causes of adrenal nodules
  • Which adrenal nodule need to be biopsied
  • Familial syndromes involving adrenal tumors
  • Incidental adrenal nodules found when staging lung cancer
  • Performing adrenal nodule needle biopsy and FNA
  • What to expect during and after adrenal surgery
  • Approach to adrenal hemorrhage
  • Radiographic imaging follow-up of adrenal nodules
  • Laboratory follow-up of adrenal nodules in patients with hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest about Pancreatic Cancer

OSUWexnerbloglogo2014 Learn Latest about Pancreatic Cancer.  It seems as though about all physicians learned about the Whipple procedure in medical school and that is what most physicians associate with the surgical treatment of pancreatic cancer. But what has happened in the 80 years since Allen Whipple did his first pancreatic surgery? Well, we now understand pancreatic cancer much better and we have a rapidly expanding repertoire of surgical procedures that can be used in pancreatic cancer. On our CME Webcast today, to tell us about the current approach to pancreatic cancer, are two of Ohio State’s top experts in the disease. First, we have Dr. Peter Muscarella who is an Associate Professor of Surgery from the Division of General Surgery.  Also joining him is Dr. Mark Bloomston, an Associate Professor of Surgery from the Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the indications for curative resection for pancreatic cancer; to RECOGNIZE the role of new chemotherapy regimens in patients with advanced pancreatic cancer; to REVIEW the epidemiology and diagnostic evaluation of pancreatic cancer; and to DESCRIBE recent advances in staging and multimodality treatment for pancreatic cancer.

You’ll also learn about the following:

  • Why pancreatic cancer frequently presents in advanced stage
  • Current treatment options for pancreatic cancer
  • Screening for pancreatic cancer
  • Biopsy approaches
  • Weight loss, diet, and pancreatic cancer
  • The role of the primary care provider in follow up of pancreatic cancer
  • Advanced endoscopic techniques and pancreatic cancer
  • Histologic types of pancreatic cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Watch Melanoma Injection and Surgery Procedure on Webcast

OSUWexnerbloglogo2014 Watch Injection and Surgery Procedure on CME Webcast for Melanoma.  Over the past 20 years, the incidence of melanoma and the death rate for melanoma have been rising.  But recently, there have been some major breakthroughs in the management of melanoma, giving some promise for a disease that previously often had very little promise. Here with our Moderator, Dr. Jim Allen, in the studio today to discuss melanoma is surgical oncologist and Assistant Professor of Surgery from the Ohio State University, Dr. Alicia Terando.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the risk factors and diagnosis of malignant melanoma; LIST the surgical and medical management modalities for localized, regional and metastatic melanoma.

You’ll also learn about the following:

  • The rising incidence of melanoma
  • Screening for melanoma
  • Staging imaging studies at the time of initial diagnosis
  • Post-surgical follow-up
  • Metastasectomy in melanoma
  • Prevention of melanoma
  • Melanoma Surgical Procedure
  • Pre-surgery Injection Procedure

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.